Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Bio-Rad Laboratories Inc. Class B
BIO.B
$
596.08
13%
Fri October 30th, 2020
07:41
Earnings
Analysis
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
Mon October 19th, 2020
17:41
Analysis
Abcam Seeks U.S. Investment For Growth Focus
Seeking Alpha
Sat August 1st, 2020
00:33
Earnings
Analysis
Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript
The Motley Fool
Tue July 14th, 2020
19:50
IPO
Analysis
IPO Update: Renalytix AI Proposes IPO Terms
Seeking Alpha
Mon June 29th, 2020
20:54
IPO
Analysis
Renalytix AI Looks For U.S. Public Capital In IPO Filing
Seeking Alpha
Tue June 16th, 2020
17:12
IPO
Analysis
IPO Update: Genetron Holdings Files Proposed IPO Terms
Seeking Alpha
